201 related articles for article (PubMed ID: 34711629)
1. Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort.
Reichard CA; Naelitz BD; Wang Z; Jia X; Li J; Stampfer MJ; Klein EA; Hazen SL; Sharifi N
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):192-199. PubMed ID: 34711629
[TBL] [Abstract][Full Text] [Related]
2. Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
Byrd DA; Zouiouich S; Karwa S; Li XS; Wang Z; Sampson JN; Loftfield E; Huang WY; Hazen SL; Sinha R
Cancer; 2024 Jun; 130(11):1982-1990. PubMed ID: 38285606
[TBL] [Abstract][Full Text] [Related]
3. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
de Vogel S; Ulvik A; Meyer K; Ueland PM; Nygård O; Vollset SE; Tell GS; Gregory JF; Tretli S; Bjørge T
Int J Cancer; 2014 Jan; 134(1):197-206. PubMed ID: 23797698
[TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
[TBL] [Abstract][Full Text] [Related]
6. Choline intake and risk of lethal prostate cancer: incidence and survival.
Richman EL; Kenfield SA; Stampfer MJ; Giovannucci EL; Zeisel SH; Willett WC; Chan JM
Am J Clin Nutr; 2012 Oct; 96(4):855-63. PubMed ID: 22952174
[TBL] [Abstract][Full Text] [Related]
7. Prospective serum metabolomic profiling of lethal prostate cancer.
Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Koutros S; Meyer TE; Fox SD; Issaq HJ; Veenstra TD; Huang WY; Yu K; Albanes D; Chu LW; Andriole G; Hoover RN; Hsing AW; Berndt SI
Carcinogenesis; 2013 Oct; 34(10):2281-5. PubMed ID: 23698636
[TBL] [Abstract][Full Text] [Related]
9. Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study.
Guertin KA; Li XS; Graubard BI; Albanes D; Weinstein SJ; Goedert JJ; Wang Z; Hazen SL; Sinha R
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):945-952. PubMed ID: 28077427
[No Abstract] [Full Text] [Related]
10. α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study.
Barry M; Dhillon PK; Stampfer MJ; Perner S; Ma J; Giovannucci E; Kurth T; Mucci LA; Rubin MA
Prostate; 2012 Feb; 72(3):301-6. PubMed ID: 21713964
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.
Albanes D; Weinstein SJ; Wright ME; Männistö S; Limburg PJ; Snyder K; Virtamo J
J Natl Cancer Inst; 2009 Sep; 101(18):1272-9. PubMed ID: 19700655
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.
Guasch-Ferré M; Hu FB; Ruiz-Canela M; Bulló M; Toledo E; Wang DD; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Lapetra J; Fitó M; Arós F; Serra-Majem L; Ros E; Dennis C; Liang L; Clish CB; Martínez-González MA; Salas-Salvadó J
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080862
[TBL] [Abstract][Full Text] [Related]
14. Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Schenk JM; Riboli E; Chatterjee N; Leitzmann MF; Ahn J; Albanes D; Reding DJ; Wang Y; Friesen MD; Hayes RB; Peters U
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1227-31. PubMed ID: 19336558
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer.
Liss MA; White JR; Goros M; Gelfond J; Leach R; Johnson-Pais T; Lai Z; Rourke E; Basler J; Ankerst D; Shah DP
Eur Urol; 2018 Nov; 74(5):575-582. PubMed ID: 30007819
[TBL] [Abstract][Full Text] [Related]
16. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
18. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
[TBL] [Abstract][Full Text] [Related]
20. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.
Johansson M; Van Guelpen B; Vollset SE; Hultdin J; Bergh A; Key T; Midttun O; Hallmans G; Ueland PM; Stattin P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1538-43. PubMed ID: 19423531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
